Price
$0.36
Decreased by -4.79%
Dollar volume (20D)
41.82 K
ADR%
6.66
Earnings report date
May 13, 2025
Shares float
19.47 M
Shares short
353.01 K [1.81%]
Shares outstanding
22.04 M
Market cap
7.94 M
Beta
-1.37
Price/earnings
N/A
20D range
0.34 0.44
50D range
0.30 0.72
200D range
0.30 2.44

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States.

The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections.

It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia; and CCP, multiple product candidates for gram-positive infections.

Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Mar 17, 25 -0.16
Increased by +56.76%
-0.18
Increased by +11.11%
Nov 13, 24 -0.17
Increased by +29.17%
-0.20
Increased by +15.00%
Aug 8, 24 -0.26
Increased by +7.14%
-0.22
Decreased by -18.18%
May 14, 24 -0.28
Decreased by -12.00%
-0.24
Decreased by -16.67%
Mar 15, 24 -0.37
Decreased by -32.14%
-0.26
Decreased by -42.31%
Nov 13, 23 -0.24
Increased by +25.00%
-0.27
Increased by +11.11%
Aug 11, 23 -0.28
Decreased by -7.69%
-0.27
Decreased by -3.70%
May 12, 23 -0.25
Increased by +3.85%
-0.29
Increased by +13.79%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Dec 31, 24 0.00
Decreased by N/A%
-2.78 M
Increased by +45.61%
Decreased by N/A%
Decreased by N/A%
Sep 30, 24 0.00
Decreased by N/A%
-2.82 B
Decreased by -90.48 K%
Decreased by N/A%
Decreased by N/A%
Jun 30, 24 0.00
Decreased by N/A%
-4.12 M
Decreased by -19.64%
Decreased by N/A%
Decreased by N/A%
Mar 31, 24 0.00
Decreased by N/A%
-4.38 M
Decreased by -50.81%
Decreased by N/A%
Decreased by N/A%
Dec 31, 23 0.00
Decreased by N/A%
-5.11 M
Decreased by -351.78%
Decreased by N/A%
Decreased by N/A%
Sep 30, 23 0.00
Decreased by N/A%
-3.11 M
Increased by +12.05%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by N/A%
-3.45 M
Decreased by -31.47%
Decreased by N/A%
Decreased by N/A%
Mar 31, 23 0.00
Decreased by N/A%
-2.90 M
Decreased by -8.72%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY